The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

Have a sex or relationship question? Ask Rachel about it using the form below or email [email protected] ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

The exterior sign at Evernorth Health Services located at One Express Scripts Way as photographed on Monday, Dec. 30, 2024, ...

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

Ozempic has always come with side effects. The latest reported by users? Thinning hair and muscle loss. Experts break down ...

What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking ...

President Donald Trump's new European tariffs may spell bad news for Novo Nordisk, maker of Ozempic and Wegovy. As Axios ...

Wegovy, the blockbuster weight-loss drug, is now available in Singapore more than two years after it was approved by the ...

Though GLP-1 drugs drive major weight loss, researchers warn they may fall short in improving heart and lung fitness.

When you hear the name Ozempic, you likely think of diabetes treatment. That makes sense, as semaglutide was first approved in 2017 to help people with type 2 diabetes regulate […] ...

GLP-1 drugs like Ozempic are transforming weight loss, but a new UVA study warns they're not improving a critical measure of ...